HRL

Hormel Foods Corp. (HRL) - Q2 2026 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended April 26, 2026, and the six months ended on that date. Hormel Foods Corporation is a global manufacturer and marketer of branded food products operating through three segments: Retail, Foodservice, and International. The company is a large accelerated filer with 550.3 million shares of common stock outstanding as of May 24, 2026.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 2.5% in Q2 and 1.9% for the six-month period. Organic net sales grew 3.3% in Q2, driven by strong performance in the turkey portfolio, Foodservice customized solutions, and the pepperoni portfolio.
• Profitability Decline: GAAP Net Earnings decreased 12.5% in Q2 and 3.2% for the six months. This decline was primarily driven by a $61.0 million pre-tax loss on the sale of the whole-bird turkey business.
• Adjusted Performance: Excluding non-recurring items, Adjusted Diluted EPS was $0.40 in Q2 (up 14% YoY) and $0.74 for the six months (up 5.7% YoY).
• Segment Results:
  • Retail: Profit up 13.5% in Q2 due to higher sales and lower SG&A, offset by logistics inflation.
  • Foodservice: Profit up 10.8% in Q2, driven by pricing actions and volume growth.
  • International: Profit up 20.3% in Q2, driven by strong exports and growth in China.
• Divestitures: Completed the sale of the whole-bird turkey business (Q2) and 51% of Justin's, LLC (Q1), resulting in a net pre-tax loss of approximately $37.5 million for the six-month period when combining the turkey loss and Justin's gain.

Guidance, Outlook, and Risks

• Outlook: Management expects net sales growth for fiscal 2026, assuming broad category growth and market-based pricing. The effective tax rate for fiscal 2026 is expected to be between 21.5% and 22.5%.
• Capital Allocation: Capital expenditures for fiscal 2026 are estimated at $260 million to $290 million. The company maintains a $750 million unsecured revolving credit facility with no outstanding borrowings as of April 26, 2026.
• Dividends: The Board authorized a quarterly dividend of $0.2925 per share for Q2 2026, a 1% increase from the prior year.
• Risks & Contingencies:
  • Legal: Pending antitrust litigation regarding turkey pricing (trial scheduled for October 2026); no liability recorded as loss is not deemed probable. Tax proceedings in Brazil regarding ICMS taxes are ongoing.
  • Market: Risks include slowing consumer demand, commodity price fluctuations, and geopolitical volatility.
  • Restructuring: A corporate restructuring plan is underway with estimated total charges of $22.0 million; $8.5 million recognized in the first six months of 2026.

Investor Verification Checklist

• Divestiture Impact: Verify the final working capital adjustments for the whole-bird turkey sale and the $40 million promissory note receivable.
• Adjusted EPS Reconciliation: Review the specific non-GAAP adjustments, particularly the $61 million loss on the turkey sale and $23.5 million gain on the Justin's sale, to understand core operating performance.
• Debt Maturity: Confirm the reclassification of $500 million of senior notes to current maturities due in March 2027 and the company's liquidity plan for repayment.
• Legal Exposure: Monitor the status of the turkey antitrust litigation and Brazilian tax proceedings for potential future accruals.
• Commodity Hedging: Assess the effectiveness of hedging programs given the noted increase in commodity input costs and logistics expenses.